|

Tailored Exercise to Reduce Aromatase Inhibitor Associated Musculoskeletal Symptoms

RECRUITINGN/ASponsored by Mahidol University
Actively Recruiting
PhaseN/A
SponsorMahidol University
Started2026-02-18
Est. completion2029-02-18
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07448558

Summary

A randomized controlled study evaluating effect of tailored exercise compared to routine practice as a preventive measure of aromatase inhibitor associated musculoskeletal related symptoms in early breast cancer patients

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* breast cancer patients with starting adjuvant aromatase inhibitor within 4 weeks
* able to read and write

Exclusion Criteria:

* chronic arthritis
* history of heart failure or acute coronary syndrome within 6 months
* individuals who exercises regularly more than 150 minutes/week

Conditions3

Breast CancerCancerPatients With Early Breast Cancer Who Initiating Adjuvant Aromatase Inhibitor

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.